Matter Bio is a longevity holding company focused on preserving genome integrity
As we age, our genome is constantly being damaged by exogenous and endogenous sources.
Occasionally errors are missed and incorporated into the DNA in the form of mutations, structural variations, epigenetic drift, and other types of information loss.
At Matter, we have assembled a world-class team of scientists and executives to help counter this critical information loss in the genome.
To achieve this, we are focusing on a number of assets that address key stages in the genomic information loss continuum.
Company Details
- Employees
- 8
- Address
- Key Stages In The Genomic Information Loss Continuum.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.matterbio.com
Matter Bio Questions
Matter Bio's website is http://www.matterbio.com
Matter Bio's LinkedIn profile is https://www.linkedin.com/company/matter-bio
Matter Bio has
8 employees.
View email and phone details for 8
employees at Matter Bio.
Matter Bio's industry is
Biotechnology Research
Matter Bio's top competitors are
Lifespan Vision Ventures,
Lucid Genomics,
Propel, Inc,
Loki Therapeutics,
Captain T Cell,
Basis,
Rutter,
Mutagentech,
Didero,
Bolden Therapeutics.
Matter Bio's categories are Biotechnology Research
